Reducing prostaglandin E2 production to raise cancer immunogenicity. (2016)

First Author: Zelenay S
Attributed to:  Overcoming immunological barriers to regenerative medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/2162402x.2015.1123370

PubMed Identifier: 27467936

Publication URI: http://europepmc.org/abstract/MED/27467936

Type: Journal Article/Review

Volume: 5

Parent Publication: Oncoimmunology

Issue: 5

ISSN: 2162-4011